Toggle navigation
Home
Search
Services
Blog
Contact
About
Production of Hybridoma
Wu, Paul
Genelabs Technologies, Inc., Redwood City, CA, United States
Search 27 grants from Paul Wu
Search grants from Genelabs Technologies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Complementary Mechanisms of Protection Against Pneumococcal Infection
Cancer Therapeutic Resistance: Implication of AcAPE1 Mediated DNA Repair and T-Cell Based Immunotherapy
Training in Cardiovascular Biology
Alzheimer's Disease Core Center
Risk Assessment and Remediation of Hazardous Waste
Recently added grants:
TMS in Primary Progressive Aphasia: Modulation of Brain Networks and Language
The Utah-Cohort Of Postnatally persistent Antenatal Hydronephrosis (U-COPAH)
Mechanisms of intestinal epithelial injury in intestinal inflammation
Role of microbiota, host genetics and mesenteric adipose in Crohn's disease fibrosis and post-op recurrence.
Innate Immunity, Cholesterol, and NASH Pathogenesis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research – Phase II (N44)
Project #
N44AI062594-003
Application #
3595492
Study Section
Project Start
1986-08-01
Project End
1988-07-31
Budget Start
1987-09-11
Budget End
1988-07-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Genelabs Technologies, Inc.
Department
Type
DUNS #
City
Redwood City
State
CA
Country
United States
Zip Code
94063
Related projects
NIH 1987
N44 AI
Production of Hybridoma
Wu, Paul / Genelabs Technologies, Inc.
NIH 1986
N44 AI
Production of Hybridoma
Wu, Paul / Genelabs Technologies, Inc.
Comments
Be the first to comment on this grant